Smoking status, alcohol consumption and HPV infection (acquired through sexual activity) are the predominant risk factors for oropharyngeal cancer and are thought to alter the prognosis of the disease. Here, we conduct epigenome-wide association studies (EWAS) of these factors and ~3year survival using Illumina Methylation EPIC blood DNA methylation profiles from 409 individuals in the Head and Neck 5000 (HN5000) study. CpG site associations below our multiple-testing threshold (PBonferroni < 0.05) with both a prognostic factor and with survival were observed in four gene regions: SPEG (smoking), GFI1 (smoking), PPT2 (smoking), and KHD3CL (alcohol consumption). These were further analysed using 2-step Mendelian randomization to assess whether methylation may be a causal mediator of cancer survival. Evidence for mediation was observed only in the SPEG gene region,
Introduction
Head and neck cancer (HNC) is the eighth most commonly diagnosed type of cancer, with over 12,000 new cases diagnosed in the UK in 2015 (1). Recently, oropharyngeal cancer (OPC), a subtype of HNC, has shown a significant increase in incidence in the UK. It has more than doubled between 1990 and 2006, with a further doubling since 2010 (2) and is affecting younger populations (<45 years old) with greater frequency (3) . OPC shows poor survival rates, with the 5-year relative survival rate for the more recently diagnosed oropharyngeal cases (between 2009-2013) estimated to be around 55-60% (4) .
Several lifestyle factors as well as viral infections have been implicated in altering both incidence and prognosis for OPC (5) (6) (7) . Of particular importance for both incidence (5, 8, 9) and prognosis of OPC (10) are smoking, alcohol intake and HPV16 infection (via sexual contact, including that of oral sex). Smoking and, to a lesser extent, heavy drinking at the time of diagnosis are both associated with increased incidence and poor prognosis (10) (11) (12) . Interestingly, HPV16 infection, while being a risk factor for OPC incidence, has been associated with better prognosis (13) (14) (15) , with a population-based study conducted in Boston from December 1999 to December 2003 demonstrating that HPV16 infected cases showed improved overall survival compared to those without an infection (HR: 0.1; 95% CI: 0.02-0.4; N: 448) (16) .
Epigenetic signatures can be measured using rapid high-throughput approaches and may serve as valuable prognostic markers for cancer (17) . While several whole-genome methylation assays have been performed to define the DNA methylation signatures of tumour samples (18, 19) , the ability to study cancers through non-invasive sampling of body fluids is a rapidly advancing development in cancer diagnostics and prognosis. In particular, biomarkers identified in blood hold promise as noninvasive prognostic tools and may potentially be used to direct treatment if shown to be informative proxies for cancer development and prognosis (20) .
Ultimately, smoking, alcohol consumption, and HPV16 infection may influence blood DNA methylation patterns which, therefore, have the potential to act as novel exposure or prognostic indicators (21) (22) (23) . Furthermore, as epigenetic changes are a hallmark process of cancer (24) , DNA methylation patterns associated with cancer survival may provide insight into biologically relevant pathways. More specifically, these epigenetic changes may act as intermediates on the pathways by which exposures influence survival. For example, as viral infections are thought to play an important role in altering epigenetic processes (25) (26) (27) , these may serve as a mechanism by which having a HPV16 infection might confer a protective effect on survival. However, distinguishing a causal mediating role of these epigenetic changes from other explanations, such as confounding and reverse causation, is challenging and requires techniques such as Mendelian randomization (MR) to strengthen causal inference (28) (29) (30) . MR is an approach which uses genetic variants strongly associated with modifiable exposures to appraise the causal effect of an exposure on disease risk. This approach has been extended to interrogate the causal relationship with molecular intermediates such as DNA methylation (29, 30) .
In the setting of a large prospective head and neck cancer cohort (the Head and Neck 5000 Study; HN5000), we profiled blood DNA methylation in 443 participants with oropharyngeal cancer close to the time of diagnosis and prior to treatment starting. We performed epigenome-wide association analyses (EWAS) of the main prognostic factors for oropharyngeal cancer (alcohol, smoking and HPV16 infection) as well as survival up to ~3 years. We then assessed overlap between the DNA methylation profiles related to these prognostic factors and survival. Where there was evidence of a shared signal, we performed Mendelian randomization analysis to appraise the causal effect of DNA methylation in mediating the effect of these factors on survival.
Results
Baseline characteristics of samples with epigenetic data, compared to all HNC and OPC samples in HN5000 are shown in Table 1 . The proportion of those under the age of 60, and the proportion of those which are HPV16 E6 seropositive (an established biomarker of HPV-driven OPC) in OPC vs non-OPC HNC is notably greater. Table 1 shows that those with OPC who were selected to have their methylation patterns typed were broadly representative of others with OPC in HN5000 with respect to exposure to prognostic factors, albeit not necessarily representative of HNC as a combined entity. (Figure 1) . CpG site cg05575921, which annotates to the AHRR gene region, was most strongly associated (P< 1.48x10 -40 ) and showed the largest effect size of -29.5% difference in methylation between ever and never smokers.
Forty-nine of the associated CpG sites had lower DNA methylation in ever smokers, with a mean difference in methylation of -8.3% (SD: 5.1%, range: -29.5% to -2.2%). The three remaining CpG sites had higher methylation in smokers, with a mean difference of 7.7% (SD: 4.2%, range: 4.7% to 12.6%). In the differentially methylated region (DMR) analysis of ever vs never smoking, 166 unique DMRs containing 617 measured CpGs and mapping to 156 gene regions were identified (Figure 1) .
Supplementary
The DMR with the strongest association contained 3 measured CpGs (cg21566642, cg01072057 and cg13903162) and was located at Chr2:233284661-233285290, an intergenic CpG island on 2q37.1 (P:1.13 x10 -46 ). 
Epigenome-wide association study of alcohol
The EWAS of alcohol consumption revealed 3 CpG site associations annotated to 3 unique genes (P<5.7x10 -8 ) (Figure 2 ). The association with the smallest p-value was cg06690548 (P:8.3x10- 16 ), annotating to the SLC7A11 gene region. This CpG site also showed the largest effect size of -0.10% difference in methylation per unit of alcohol increase. All results below the 450K array multiple testing threshold of 2.4x10 -7 are shown in Supplementary Table 2. Of the results presented in this table, 40% of the CpGs (2/5 CpGs) were present on the EPIC array but not it's 450K predecessor.
In the DMR analysis of alcohol consumption, 40 unique DMRs containing 238 measured CpGs and mapping to 34 gene regions were identified (Figure 2) . The DMR with the smallest P value was a region containing 2 CpGs (cg06690548 and cg13903162) found at Chr4:139162808-139163020 (P:1.45 x10-10 ), annotating to the SLC7A11 gene region. 
Epigenome-wide association study of HPV seropositivity
In the EWAS analysis of HPV16 E6 seropositivity, no CpGs passed our multiple testing pvalue threshold (P<5.7x10 -8 ) (Figure 3) . At a suggestive threshold of 2.4x10 -7 , only 1 CpG site (cg26738437; P:1.3x10 -7 ) was found, annotating to the CCL16 gene. This probe is not found on the 450K array. Methylation at this site was on average 2.3% lower in HPV16 E6 seropositive participants when compared to controls.
In the DMR analysis of HPV16 E6 seropositivity, 31 unique DMRs pertaining to 158 CpGs and annotating to 38 gene regions were identified (Figure 3) . The most associated DMR was a region of 13 CpGs found at Chr5:110062343-110062838 (P:4.10x10-6 ), annotating to the TMEM232 gene region. 
Epigenome-wide association study of OPC survival
Model 1
In the single-site analysis of survival (adjusting for age, sex and surrogate variables obtained by SVA (32)), three CpGs mapping to three unique loci showed association with survival below the multiple testing p-value threshold (P<5.7e -8 ) (Figure 4) . One CpG site showed lower methylation in those who died vs were alive during follow-up. This site was also the most strongly associated with survival, annotating to PAQR3 and showed the largest effect size among the top hits (cg25864218; β [difference in methylation between those that were dead vs alive before 30 th September 2017]: -2.54%; P: 1.04e-9 ). Two sites showed higher methylation in those who died vs were alive during follow-up in our analysis, annotating to DNAH11 (cg07377396; β: 0.49%; P: 3.39e-8 ) and MYBPC1 (cg12151015; β: 0.11%; P: 7.51e-9 ). The mean difference in methylation in these sites was 0.3% (SD: 0.27%, range:
0.11% to 0.49%). All results below a suggestive multiple testing threshold of 2.4e -7 are shown in Supplementary Table 3 .
In the DMR analysis of survival, 142 unique DMRs pertaining to 805 CpGs and annotating to 153 gene regions were identified ( Figure 5 ). The DMR with the lowest P value was a region of 10
CpGs found at Chr17:33814297-33814897 (P:5.26e- 21 ), annotating to the CDK16 gene region. 
Model 2
In the single-site analysis of survival using Model 2 (adjusting for age, sex, surrogate variables obtained by SVA (32), HPV16E6 seropositivity, smoking status and alcohol intake ), 6 CpGs annotated to 4 unique loci showed a p-value of association below our multiple testing threshold (P<5.7e -8 ) ( Figure   5 ). Three of the 6 CpGs passing multiple testing correction showed lower methylation in those who died vs were alive during follow-up in our analysis, while the other 3 showed higher methylation. Of the 3 sites showing lower methylation, the mean difference in methylation between those that were dead vs alive after ~3-year follow-up was -0.07% (SD: 0.05%, range: -2.54% to -0.16%). For the 3 sites showing higher methylation, the mean difference in methylation was 0.31% (SD: 0.31%, range: 0.11% to 0.67%). The CpG with the smallest P value (cg25864218, P: 1.22x10 -8 ), annotates to the PAQR3 gene region. This CpG site also showed the largest effect size of -2.5% difference in methylation between those who are dead vs alive in this analysis. Other CpGs passing our multiple testing correction which were annotated to genes included MYBPC1 (cg12151015; β: 0.11%; P: 2.59e-8 ), GRIN2A (cg08204867; β: -0.16%; P: 2.87e-8 ), and IL15 (cg26269613; β: 0.67%; P: 5.34e-8 ). Two CpGs showed an association with survival in both models: cg12151015 (annotating to MYBPC1) and cg25864218
(annotating to PAQR3). All results below a suggestive multiple testing threshold of 2.4e -7 are shown in Supplementary Table 4 . Interestingly, of the results presented in this table, all 23 associated CpGs were present on the EPIC array but not the 450K predecessor.
In the DMR analysis of survival (model 2), 157 unique DMRs pertaining to 874 CpGs and annotating to 177 gene regions were identified ( Figure 5 ). The DMR with the lowest P value was a region of 12 CpGs found at ChrX: 47077168-47077877 (P:1.08e- 21 ), annotating to the CDK16 gene region.
Figure 5 -Manhattan plot of EWAS of survival (model 2 -adjusted for smoking, alcohol consumption and HPV16E6 seropositivity), showing CpG sites within DMRs in red. Each dot represents the EWAS result for a single CpG site, plotting -log10(p) (y-axis) against the genomic position of the CpG site (x-axis). The horizontal red line is at P<5.7x10 -8 and represents
the value below which CpG sites were considered to have good evidence of association with survival.
DMR overlap between OPC risk factors and survival
Eighteen unique CpGs overlapped between all smoking DMRs and survival DMRs (survival EWAS model 1). These CpGs belonged to 3 unique DMRs (annotated to GFI1, SPEG and PPT2); five CpGs overlapped between all alcohol DMRs and survival (EWAS Model 1) DMRs, all pertaining to a single DMR (annotated to C6orf221) (Supplementary Table 5 ). No CpGs overlapped at our p-value threshold for HPV DMRs and survival (EWAS model 1) DMRs.
Of the 18 CpGs which overlapped between smoking and survival, 15 possessed mQTL proxies in the Generation Scotland summary data with which to conduct MR (see Methods). Of the 5 CpGs which overlapped between alcohol and survival, 3 possessed mQTL proxies in the Generation Scotland summary data ( Supplementary Table 5 ).
Mendelian randomization: DNA methylation -OPC survival
Tables 2a-c and Figure 8 show the results MR analyses for the association of mQTL-proxied DNA methylation, at CpG sites associated with smoking and survival, with 3-year survival in HN5000.
In our analyses, there appears to be some evidence for a potential causal effect of decreased DNA methylation on survival at the SPEG gene locus (Table 2a ; Chr2:22035443-22036041; HR: 1.28; 95% CI: 1.14 to 1.43). Our results provide evidence of a causal association seen between methylation changes in response to smoking, and decreased survival at this gene region. A lookup in the BIOS QTL Browser (https://genenetwork.nl/biosqtlbrowser/) was conducted to assess whether methylation at this locus affected gene expression; twenty cis-expression quantitative trait methylations (eQTMs) showed evidence of correlation between gene expression and methylation at the SPEG locus in whole blood at this gene region.
The GFI1 (Table 2b ) and PPT2 (Table 2c ) gene regions appear to show no consistent evidence of a causal effect of DNA methylation on survival. We could only conduct multivariable MR Egger analysis using independent SNPs (multivariable MR Eggerindependent: a sensitivity analysis for using multivariable MR Egger with correlated SNPs in our main analysis) at the SPEG locus, as other regions did not have sufficient independent SNPs as proxies. Fewer than 3 SNPs greatly reduces the accuracy of MR Egger; therefore, it was only used in analyses with 3 or more SNP proxies. Multivariable MR Eggerindependent showed a similar effect estimate to normal multivariable MR Egger at this locus, albeit with larger confidence intervals, suggesting the confidence interval for normal multivariable MR Egger is likely to be overly precise in this analysis. Table 3 and Figure 9 show the results of the associations of mQTL-proxied DNA methylation, at CpG sites associated with alcohol and survival with 3-year survival in HN5000. In our analysis, there appears to be no consistent evidence for a causal effect of DNA methylation on survival at the C6orf221 gene locus (Chr6:74072255-74072376). 
Discussion
We undertook EWAS analyses and identified CpG sites and DMRs associated with smoking and alcohol consumption, but none associated with HPV infection. We also identified 6 CpGs associated with OPC survival at 3 years post-diagnosis. Twenty-three CpGs at 4 DMRs were identified in both analyses of risk factor and of survival. We hypothesised that for these CpG sites, DNA methylation could mediate part of the association between the risk factor and OPC survival. MR
analysis was conducted to test this hypothesis and we found preliminary evidence to support this mediation pathway between smoking and OPC survival at the SPEG gene locus.
In relation to smoke exposure, our results include several previously reported loci, notably those mapping to AHRR and PRSS23. The effect size seen in our EWAS for cg05575921 (29.5%) is markedly stronger than the largest published smoking EWAS analysis; Joehanes et al (21) report 18% lower methylation in current smokers compared to those who have never smoked (P: 4.60e-26 ). A potential explanation for this finding could be that our analysis was conducted in a case-only setting where smoking is one of the predominant risk factors for HNC and smoking intensity is likely to be higher in HN5000 smokers compared to smoking in the general population. We completed a lookup of our top smoking CpG sites (P < 5.7e-8), using the EWAS Catalog (http://www.ewascatalog.org/) online tool to compare whether our effect sizes were consistently stronger than other published smoking EWAS findings ( Supplementary Table 6 ). Of the 52 sites below a multiple-testing correction, 20 had not been previously reported in published EWASs. The other 32 CpG sites which had previously been reported in the literature showed consistently larger effect estimates in response to smoking in our analysis compared to a weighted mean (weighted by sample size) of published EWAS beta values.
None of the 5 CpG associations with alcohol were replicated in data from the EWAS catalog.
However, CpGs associated with alcohol were specific to the EPIC array and no other EPIC array
EWASs of alcohol are currently indexed by the EWAS catalog. SLC7A11, the gene annotated to our top CpG site associated with alcohol consumption, is essential for glutathione synthesis, a component of the KEAP1-NRF2-CUL3 axis, and strongly associated with poor prognosis in The Cancer Genome Atlas (TCGA) HNC cohort (35, 36) .
In our EWAS of 3-year survival none of the 15 (model 1) or 23 (model 2) reported associations have previously been reported in published studies of OPC survival. Both survival EWAS models gave a top hit annotating to the PAQR3 gene. Aberrant promotor methylation at this gene has been shown to be associated with prostate cancer (37) , with the gene itself being an established tumour suppressor (38) . Within the context of HNC, PAQR3 has been associated with tumorigenesis in oesophageal cancer (39, 40) , although to our knowledge no literature has examined whether this gene affects oropharyngeal cancer specifically.
The consistent direction of effect between MR Egger, MR Eggerindependent and Burgess IVW estimates for the SPEG locus provide us with greater confidence that the IV is reliable and that there is sufficient statistical power to demonstrate preliminary evidence for a causal association with decreased survival. Expression of the SPEG gene shows specificity to vascular smooth muscle cellsthe major cell type in blood vessel walls, in which smoking has been shown to produce abnormal function throughout the body (41) . Functional annotations show the SPEG gene to be essential for cardiac function in particular, with deficiency of this gene reported to result in heart failure (42 It should be noted that, despite being an established biomarker with high sensitivity (>93%) and specificity (>94%) for HPV-driven OPC (46) , HPV16 E6 seropositivity may underestimate the number of individuals in our data with a current HPV-driven disease; they may be yet to present with the disease. Additionally, it has been reported that HPV can colocalise to biofilm (a community of immotile bacteria encased in a self-produced glycocalyx matrix) in tonsillar crypts, representing a reservoir of latent oncovirus undetected by the immune system (47) . Therefore, it is also possible that individuals in our data have a historically HPV16-driven OPC without evidence of infection at time of assessment. As such, our EWAS results for HPV16 infection may be biased towards the null in both instances.
Collider bias may influence associations between our prognostic factors and progression in a
case-only setting (48) . HPV, smoking and alcohol are all associated with OPC incidence; by only examining cases, incidence is conditioned on, potentially inducing an association between HPV, smoking, alcohol and any unmeasured confounding. Unmeasured, unknown, confounding cannot be adjusted for here, so if any unmeasured confounding is associated with survival, it may be that an association between a prognostic factor and survival is simply a result of the induced association of the prognostic factor and unmeasured confounding.
Some of our MR analyses highlight potential violations of its methodological assumptions.
Primarily, those analyses where the MR Egger estimate shows an opposite direction of effect to the IVW estimate (GFI1, PPT2, KHDC3L) could indicate an IV where one or more of the genetic variants proxying methylation is disproportionately skewing the effect in a certain direction (horizontal pleiotropy). However, for each of these analyses, the MR Egger intercept test of heterogeneity (explained elsewhere (33, 34)) spans 0 (GFI1 intercept: -0.25, 95% CI: -0.54 to 0.05, p-value: 0.10;
PPT2 intercept: -0.18, 95% CI: -0.58 to 0.23, p-value: 0.40; KHDC3L intercept: 0.07, 95% CI: -0.09 to 0.23, p-value: 0.37), indicating that directional pleiotropy is not causing the difference between the MR Egger and IVW estimates. A possible explanation of this finding, and one that we cannot rule out, is that these analyses suffer from weak instrument bias; a bias where the chance difference in confounders may explain more of the difference in phenotype between genotype subgroups than the instrument, thereby confounding the true causal estimate. Finally, in these three analyses, we cannot state the true direction of effect with confidence, given that our confidence intervals span our null line of Y = 1; this is likely an artefact of low statistical power.
One notable limitation of our MR analysis is that it is likely particularly conservative as we assessed overlap between prognostic factor DMRs and survival DMRs only if they surpassed our multiple correction threshold in both analyses. We adopted this approach (rather than to test corrected prognostic factor DMRs for association with all survival DMRs, only correcting for a number of tests equal to the number of prognostic factor DMRs) to improve confidence that regional methylation was associated with both a prognostic factor and survival. In order to reduce the possibility that regional methylation was only associated with a prognostic factor (and only spuriously associated with survival),
we may have missed genuine causal mediation at less-stringent p-value thresholds.
Conclusions
Within the context of OPC, we found novel epigenetic biomarkers measured by the Illumina Infinium EPIC array to be associated with the prognostic factors of smoking and alcohol and with survival. Of these biomarkers, we used overlapping signals between prognostic factor and survival analyses to conduct MR analysis to appraise the causal role of DNA methylation. Using an IVW approach to investigate the causal effect of DNA methylation at the identified sites, we found that a collection of CpGs located within a DMR associated with smoking (located at Chr2:220325443-220326041; annotating to the SPEG gene) showed some evidence of a causal effect on decreased survival (HR: 1.28, 95% CI: 1.14 to 1.43, P: 2.12x10 -05 ). DNA methylation at this locus could potentially mediate some of the association between smoking and OPC survival. To strengthen the validity of these findings, replication analyses in other studies, and a longer follow-up period in Head and Neck 5000 are recommended.
Methods

Study population
The study population for this analysis were individuals enrolled in the Head and Neck 5000 (HN5000) clinical cohort study. Full details of the study methods and overall population are described in detail elsewhere (49, 50) . 
Baseline data collection
Participants completed a series of three self-administered questionnaires at baseline enquiring about: 1) social and economic circumstances, overall health and lifestyle behaviours; 2) physical and psychological health, well-being and quality of life; and 3) past sexual history and behaviours (49) .
Information on diagnosis, treatment and co-morbidity was recorded on a short data capture form using questions based on a national audit (52) . Diagnoses were coded using the International Classification of Diseases (ICD) version 10 (53) and clinical staging of the tumour was derived based on the American Head and Neck Society TNM staging (54) .
Research nurses collected a blood sample from all consenting participants (49) . These were then sent to the study centre laboratory at ambient temperature for processing. The blood samples were centrifuged at 3500 rpm for 10 minutes and the buffy coat layer used for DNA extraction. Any additional samples from the same participant were frozen and stored at -80°C.
Assessment of tobacco, alcohol and HPV infection
Detailed information on tobacco and alcohol history was obtained at baseline via the selfadministered questionnaire. Participants were asked about their current smoking and drinking status and their use of tobacco and alcohol products prior to receiving their HNC diagnosis.
Among smokers, information on age at smoking initiation and number of years of smoking was obtained. The questionnaire differentiated between use of cigarettes, hand-rolled cigarettes, cigars and smokeless tobacco, whereby a cigar was considered equivalent to four cigarettes. From this information, participants were dichotomised into ever and never smokers. Ever smokers were defined as those who smoked at the equivalent of at least 1 tobacco product a day per year, or ≥100 cigarettes in their lifetime.
Never smokers were those who reported not smoking in any of the questions answered.
Respondents were asked to report their average weekly alcohol consumption of a range of beverage types (wine, spirits, and beer/larger/cider) before they were diagnosed with cancer. From these measures, we derived an average intake of alcohol consumption in units per week.
HPV serologic testing (HPV16 E6, E7, E1, E2, E4, and L1) was conducted at the German Cancer Research Center (DKFZ, Heidelberg, Germany) using glutathione S-transferase multiplex (55) .
Median fluorescence intensity (MFI) values were dichotomized to indicate HPV16 E6 seropositivity using a cut-off of ≥ 1000 MFI (56) . E6 seropositivity is known to be a marker of with a high sensitivity and specificity for HPV16-driven oropharyngeal cancer (57) .
Study follow-up and survival
Regular updates were received from the NHS Central Register (NHSCR) and the NHS 
DNA methylation
Data generation
Following extraction, DNA was bisulphite-converted using the Zymo EZ DNA Methylation TM kit (Zymo, Irvine, CA, USA). Genome-wide methylation data were generated using the Infinium MethylationEPIC BeadChips (EPIC array) (Illumina, USA) according to the manufacturer protocol.
The arrays were scanned using an Illumina iScan (version 2.3).
Pre-processing
Raw data files (IDAT files) were pre-processed using the R package meffil CpG site was calculated as a beta value (β), which is the ratio of the methylated probe intensity and the overall intensity and ranges from 0 (no cytosine methylation) to 1 (complete cytosine methylation).
EWAS
Epigenome wide association study (EWAS) analysis was conducted to identify associations between DNA methylation and 1) alcohol consumption 2) smoking status and 3) HPV16E6 Table 7 ). Therefore, we conducted EWAS of survival without stage and comorbidity as covariates.
Due to the large number of tests conducted in our EWAS, we employed a Bonferroni correction to derive a conservative p-value threshold of 5.7 x10 -8 (0.05/862491 independent tests) to determine those sites showing strong evidence of association with our risk factor of interest or survival, respectively. We also used the alpha value calculated for the Illumina 450K array (the predecessor to the MethylationEPIC array) as a p-value threshold of 2.4 x 10 -7 for suggestive evidence of association (31) .
DMR analysis
Adjacent 
Generation of instrumental variables for DMRs
Prior to MR analysis being conducted (see below), we generated instrumental variables (IVs)
proxying CpG sites identified in analyses of both prognostic factors and survival ( Supplementary   Figure 1) . Where possible, we found DMRs (P < 0.05) from our analyses for each prognostic factor and located DMRs spanning the same region in our survival analysis (Model 1unadjusted for prognostic factors; P < 0.05). CpG sites present in both DMRs were retained.
Next, using the summary genetic data for mQTLs from Generation Scotland, we extracted all mQTLs proxying any CpG site per DMR grouping (MAF >0.05; P < 5x10-8). From this list, we generated instruments by LD pruning iteratively; first taking all mQTLs associated with the sentinel CpG (defined as the CpG in each DMR with the lowest p-value) and clumping with an r 2 of 0.01. We then took the second most-associated CpG in the DMR and extracted all mQTLs associated with it which were not associated with the previous CpG. The remaining mQTLs were then clumped and combined with the mQTLs proxying the sentinel CpG. This process was repeated for each CpG within a DMR. Clumping and mQTL extraction were conducted using R 3.4.1, with the TwoSampleMR R package (74) .
In order to account for mQTL proxies influencing methylation at multiple CpG sites, we conducted a meta-analysis of mQTL-CpG effects. Per DMR, we used the metafor R package (75) to meta-analyse each mQTL effect (beta) on methylation levels at each CpG using a restricted maximum likelihood (REML) model, adjusting for pairwise correlation between the CpG sites proxied by our instrument. From this, we obtained an mQTL effect on average methylation levels across the DMR. 
Mendelian randomization analyses
Following identification of shared methylation patterns between prognostic factors and OPC survival, we attempted to ascertain whether methylation was a true causal intermediate, or simply just associated with both prognostic factors and survival. To this end, we conducted two-sample Mendelian randomization to appraise the causal effect of DNA methylation on survival. In the first sample, we used mQTL-DMR effect estimates (βGP) from Generation Scotland and in the second sample, mQTLsurvival estimates (βGD) from HN5000. For each mQTL, we calculated the log HR per unit (β) increase in DNA methylation at the DMR by the formula βGD/βGP (Wald ratio). Standard errors were approximated by the delta method. Where multiple mQTLs were available for one DMR, these were combined in a fixed effects meta-analysis after weighting each ratio estimate by the inverse variance of their associations with the outcome (IVW approach). In order to account for correlation between mQTLs, we adjusted for genetic correlation using LDMatrix (77) to generate a genetic correlation matrix (1000 Genomes reference standard (78)) of mQTLs, which was included as a covariate in our MR regression analysis (79) . In addition to our main analysis detailed above, we conducted multivariable MR Egger analysis as an assessment of IV heterogeneity using the MendelianRandomization R package (80) . We also conducted sensitivity MR analyses by calculating the log HR per unit increase in DNA methylation for the sentinel CpG within each DMR we analysed.
As above, Wald ratios were calculated for CpGs proxied by a single mQTL and IVW MR estimates were calculated when multiple mQTLs were available to proxy a CpG. Finally, where possible, we conducted multivariable MR Egger analysis on a subset of independent SNPs for each DMR as a sensitivity analysis for using multivariable MR Egger with correlated SNPs in our main analysis. 
